Skip to main content

Peer Review reports

From: Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood

Original Submission
15 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Feb 2021 Reviewed Reviewer Report
11 Feb 2021 Reviewed Reviewer Report - Sanjay Rathod
5 Apr 2021 Author responded Author comments - Jihane Boustani
Resubmission - Version 3
5 Apr 2021 Submitted Manuscript version 3
10 Apr 2021 Author responded Author comments - Jihane Boustani
Resubmission - Version 4
10 Apr 2021 Submitted Manuscript version 4
5 May 2021 Reviewed Reviewer Report - Sanjay Rathod
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
13 May 2021 Editorially accepted
18 Jun 2021 Article published 10.1186/s12865-021-00429-5

You can find further information about peer review here.

Back to article page